Related Experiment Videos
Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles
1F. Q. Hu, School of Pharmaceutical Science, Zhejiang University, 353, Yanan Road, Hangzhou 310031, PR China.
Die Pharmazie
|May 3, 2006
Summary
This study developed PEG2000-modified solid lipid nanoparticles (SLN) for drug encapsulation. PEG2000-modified SLN demonstrated accelerated drug release compared to unmodified SLN.
Area of Science:
- Pharmaceutical Nanotechnology
- Drug Delivery Systems
Background:
- Solid lipid nanoparticles (SLN) are a promising drug delivery system.
- Modification of SLN can alter drug release profiles.
Purpose of the Study:
- To develop and characterize PEG2000-modified SLN for drug encapsulation.
- To investigate the effect of PEG2000 modification on drug release.
Main Methods:
- SLN were prepared using a solvent diffusion method in an aqueous system.
- Monostearin was used as the carrier material, and PEG2000 as the modifying agent.
- Salbutamol sulphate was used as a model drug to characterize entrapment efficiency, size, zeta potential, and drug release.
Main Results:
- Drug-loaded SLN exhibited a biphasic release pattern in pH 7.2 phosphate buffer.
- Monostearin-based SLN showed prolonged drug release over 14 days after an initial burst release.
- PEG2000-modified SLN demonstrated a faster drug release rate compared to unmodified SLN.
Conclusions:
- PEG2000 modification can accelerate the release of hydrophilic small molecule drugs from SLN.
- Further optimization is needed to tailor release behavior for various drugs.
- Developed PEG2000-modified SLN show potential for specific drug delivery applications.